1-7 of 7
Petros P. Sfikakis
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Discovering the Epigenetic Modifications and the Alterations in Cellular DNA Damage Response Pathways That Drive Myelomagenesis; Clinical Implications Into the Biology of Multiple Myeloma

Maria Gkotzamanidou, Evangelos Terpos, Petros P. Sfikakis, Meletios Athanasios Dimopoulos, MD, Vassilis L. Souliotis
Journal: Blood
Blood (2011) 118 (21): 299.
https://doi.org/10.1182/blood.V118.21.299.299
Published: 2011
Journal Articles

Differences In DNA Damage Response Pathways In the PBMCs of Patients with MGUS, Asymptomatic Myeloma and Symptomatic Multiple Myeloma

Vassilis L. Souliotis, Maria Gkotzamanidou, Petros P. Sfikakis, Evangelos Terpos, Soterios A. Kyrtopoulos, Meletios A. Dimopoulos
Journal: Blood
Blood (2010) 116 (21): 2974.
https://doi.org/10.1182/blood.V116.21.2974.2974
Published: 2010
Journal Articles

Reduced Repair Efficiency Correlates with Increased Cellular Chemosensitivity and Better Response to High Dose Melphalan of Patients with Multiple Myeloma

Vassilis L. Souliotis, Maria Gkotzamanidou, Petros P. Sfikakis, Evangelos Terpos, Christos Papadimitriou, Magdalini Migkou, Evangelos Eleutherakis-Papaiakovou, Nikitas Nikitas, Efstathios Kastritis, Soterios A. Kyrtopoulos, Meletios A. Dimopoulos
Journal: Blood
Blood (2010) 116 (21): 2976.
https://doi.org/10.1182/blood.V116.21.2976.2976
Published: 2010
Journal Articles

Alterations in the Epigenetic Network Controlling Transcription Activity, Chromatin Structure and Region-Specific Repair of Different Genomic Loci Predicts Clinical Outcome in Multiple Myeloma.

Hara G. Episkopou, Soterios A. Kyrtopoulos, Petros P. Sfikakis, Maria Fousteri, Evangelos Terpos, Leon H. Mullenders, Vassilis L. Souliotis, Meletios A. Dimopoulos
Journal: Blood
Blood (2009) 114 (22): 122.
https://doi.org/10.1182/blood.V114.22.122.122
Published: 2009
Journal Articles

A Polymerase Chain Reaction-Based Method to Detect Gene-Specific Adducts Induced by Anticancer Drugs. Clinical Application in Multiple Myeloma.

Meletios A. Dimopoulos, Christine Liakos, Hara G. Episkopou, Dimitra T. Stefanou, Soterios A. Kyrtopoulos, Petros P. Sfikakis, Evangelos Terpos, Aristotelis Bamias, Vassilis L. Souliotis
Journal: Blood
Blood (2009) 114 (22): 1879.
https://doi.org/10.1182/blood.V114.22.1879.1879
Published: 2009
Journal Articles

Melphalan-Induced DNA Damage In Vitro as Predictor for Clinical Outcome in Multiple Myeloma.

Meletios A. Dimopoulos, MD, Vassilis L. Souliotis, PhD, Athanasios Anagnostopoulos, M.D., Christina Bamia, PhD, Anastasia Pouli, M.D., Ioannis Baltadakis, M.D., Evangelos Terpos, M.D., Soterios A. Kyrtopoulos, PhD, Petros P. Sfikakis, M.D.
Journal: Blood
Blood (2006) 108 (11): 60.
https://doi.org/10.1182/blood.V108.11.60.60
Published: 2006
Journal Articles

Measurement of Individual p53-Specific Damage Formation and Repair Following In Vitro Exposure of Peripheral Mononuclear Cells to Melphalan May Predict Clinical Outcome in Patients with Multiple Myeloma (MM) Subsequently Treated with High Dose Melphalan (HDM) and Autologous Blood Stem Cell Transplantation (ASCT).

Meletios A. Dimopoulos, MD, V. L. Souliotis, PhD, A. Anagnostopoulos, MD, A. Pouli, MD, I. Baltadakis, MD, E. Terpos, MD, Petros P. Sfikakis, MD
Journal: Blood
Blood (2005) 106 (11): 1167.
https://doi.org/10.1182/blood.V106.11.1167.1167
Published: 2005